New anthrax vaccine doomed by lobbying

[Robbien]

Source: LATimes

America's sole supplier faced oblivion if its rival's product was adopted. It was time to call on political connections.
By David Willman, Los Angeles Times Staff Writer
December 2, 2007

The existing vaccine often caused swollen arms and muscle and joint pain. Inoculation required six injections over 18 months, followed by yearly booster shots. The estimated shelf life was just three years.

. . .

The manufacturer, Emergent BioSolutions Inc. of Rockville, Md., prevailed in a bitter struggle with a rival company that was preparing what federal health officials expected to be a superior vaccine. The episode illustrates the clout wielded by well-connected lobbyists over billions in spending for the Bush administration's anti-terrorism program.

Emergent's rival, VaxGen Inc. of South San Francisco, had spent four years developing a new anthrax vaccine and had won an $877.5-million federal contract to deliver enough doses for 25 million people. The contract threatened Emergent's very existence. The old vaccine, its only moneymaker, would likely be obsolete if VaxGen succeeded.

Emergent responded by mobilizing more than 50 lobbyists, including former aides to Vice President Dick Cheney, to make the case that relying on the new vaccine was a gamble and that the nation's safety depended on buying more of Emergent's product.

The company and its allies in Congress ridiculed VaxGen and impugned the competence or motives of officials who supported the new vaccine. The lobbying effort damaged VaxGen's credibility with members of Congress and the Bush administration, a Los Angeles Times investigation found.

Read more: http://www.latimes.com/news/nationworld/nation/la-na-anthrax2dec02,0,3465779,full.story?coll=la-home-center

---

A reading of the full article can make one's blood boil. Don't understand why this investigation was released on a weekend. LATime investigative costs down the drain since few will see it.